Friday, July 30, 2021

Lupin acquires Melbourne-based drug maker SCP to bolster Australia generics business

Lupin acquires Melbourne-based drug maker SCP to bolster Australia generics business As a part of the transaction, Lupin will gain access to over 60 registered products having sales of over AUD 30 million

from Moneycontrol Business News https://ift.tt/3BWpqWx
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

MSCI to drop Swiggy from global indices on September 7

Global index providers MSCI and FTSE are set to revise Swiggy's index treatment shortly. MSCI is removing Swiggy from global indices, wh...